- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Narrow-spectrum antibiotics suffice in stable patients of diabetic foot infection after surgical debridement
Researchers have found in a new study that narrow-spectrum antibiotics are as effective as broad-spectrum following surgical debridement in stable patients with local diabetic foot infections.
Arend J. Nieuwland et al. and colleagues have concluded that the microbiological adequacy of the initial antibiotic regimen after (surgical) debridement for diabetic foot infections or DFI did not alter therapeutic outcomes. They recommended clinicians follow the stewardship approach of avoiding antibiotic de-escalation and start with a narrow-spectrum regimen (local epidemiology based).
Researchers from the Balgrist University Hospital and the University of Washington evaluated clinical and microbiological outcomes following combined surgical and medical therapy for DFI (empirical versus the targeted nature and empirical broad versus a narrow-spectrum antibiotic therapy).
They assessed the therapeutic failure rate for adequate empirical, culture-guided, and empirical inadequate therapy with a switch to targeted treatment based on available microbiological results.
The key results of the study are:
- Researchers included data from 332 patients.
- These patients underwent 716 DFI episodes of surgical debridement, including partial amputations.
- 40/190 episodes (20/6 %), 77/291 episodes (26.5%), and 73/231 episodes (31.6%) had Clinical failure where adequate empirical therapy, culture-guided (and correct) therapy from the start, and switching from empirical inadequate to culture-targeted therapy were provided respectively.
- This failure risk could not be altered by broad-spectrum antibiotic choice.
They said, “We found that selecting an initial broad-spectrum antibiotic regimen failed to reduce clinical failure risk in treating localized DFIs.
They noted that our findings regarding effective antibiotic stewardship in global management are crucial.
The researchers advocate for considering a narrow-spectrum postoperative antibiotic regimen in stable patients with local DFIs that have been surgically debrided.
Further reading:
Nieuwland AJ, Waibel FWA, Flury A, Lisy M, Berli MC, Lipsky BA, Uçkay İ, Schöni M. Initial antibiotic therapy for postoperative moderate or severe diabetic foot infections: Broad versus narrow spectrum, empirical versus targeted. Diabetes Obes Metab. Published ahead of print on August 2, 2023. doi 10.1111/dom.15228.
BDS, MDS in Periodontics and Implantology
Dr. Aditi Yadav is a BDS, MDS in Periodontics and Implantology. She has a clinical experience of 5 years as a laser dental surgeon. She also has a Diploma in clinical research and pharmacovigilance and is a Certified data scientist. She is currently working as a content developer in e-health services. Dr. Yadav has a keen interest in Medical Journalism and is actively involved in Medical Research writing.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751